Fort Washington Investment Advisors Inc. OH Grows Holdings in Option Care Health, Inc. $OPCH

Fort Washington Investment Advisors Inc. OH increased its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 13.1% in the fourth quarter, Holdings Channel reports. The firm owned 1,437,411 shares of the company’s stock after buying an additional 166,726 shares during the quarter. Fort Washington Investment Advisors Inc. OH’s holdings in Option Care Health were worth $45,796,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently bought and sold shares of OPCH. Swedbank AB purchased a new position in shares of Option Care Health in the 3rd quarter valued at approximately $49,455,000. Boston Partners raised its stake in shares of Option Care Health by 34.8% during the second quarter. Boston Partners now owns 952,299 shares of the company’s stock worth $30,311,000 after purchasing an additional 245,990 shares during the last quarter. Prudential Financial Inc. lifted its holdings in shares of Option Care Health by 32.6% during the second quarter. Prudential Financial Inc. now owns 396,158 shares of the company’s stock worth $12,867,000 after purchasing an additional 97,465 shares during the period. Aristides Capital LLC acquired a new stake in shares of Option Care Health during the second quarter worth $249,000. Finally, Pacer Advisors Inc. purchased a new position in Option Care Health in the 3rd quarter valued at $593,000. 98.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages have issued reports on OPCH. Wall Street Zen cut shares of Option Care Health from a “buy” rating to a “hold” rating in a research note on Saturday, February 28th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Option Care Health from $31.00 to $36.00 and gave the company a “buy” rating in a report on Tuesday, December 9th. National Bank Financial set a $37.00 price target on shares of Option Care Health in a research note on Tuesday, January 27th. Stephens raised shares of Option Care Health to a “strong-buy” rating in a report on Thursday, December 11th. Finally, Barrington Research raised their price objective on shares of Option Care Health from $38.00 to $42.00 and gave the company an “outperform” rating in a research report on Friday, January 16th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $37.27.

Option Care Health Price Performance

Shares of NASDAQ OPCH opened at $27.75 on Friday. The company has a debt-to-equity ratio of 0.87, a quick ratio of 0.96 and a current ratio of 1.53. Option Care Health, Inc. has a one year low of $24.24 and a one year high of $36.80. The firm has a market capitalization of $4.34 billion, a P/E ratio of 21.68, a PEG ratio of 1.60 and a beta of 0.85. The company’s fifty day moving average is $32.77 and its two-hundred day moving average is $30.72.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings data on Tuesday, February 24th. The company reported $0.46 EPS for the quarter, meeting the consensus estimate of $0.46. The firm had revenue of $1.47 billion during the quarter, compared to analysts’ expectations of $1.46 billion. Option Care Health had a net margin of 3.67% and a return on equity of 18.57%. The business’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same quarter last year, the business earned $0.44 earnings per share. Analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.